TP63
Tumor protein 63
Also known as: EEC3, KET, NBP, OFC8, p40, p51, p53CP, p63, P63_HUMAN, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H3D4
- Gene
- TP63
- Ensembl
- ENSG00000073282
- Chromosome
- 3
- Canonical length
- 680 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]
Canonical amino-acid sequenceUniProt
680 residues, UniProt reviewed canonical sequence.
>Q9H3D4|TP63
1 MNFETSRCAT LQYCPDPYIQ RFVETPAHFS WKESYYRSTM SQSTQTNEFL SPEVFQHIWD
61 FLEQPICSVQ PIDLNFVDEP SEDGATNKIE ISMDCIRMQD SDLSDPMWPQ YTNLGLLNSM
121 DQQIQNGSSS TSPYNTDHAQ NSVTAPSPYA QPSSTFDALS PSPAIPSNTD YPGPHSFDVS
181 FQQSSTAKSA TWTYSTELKK LYCQIAKTCP IQIKVMTPPP QGAVIRAMPV YKKAEHVTEV
241 VKRCPNHELS REFNEGQIAP PSHLIRVEGN SHAQYVEDPI TGRQSVLVPY EPPQVGTEFT
301 TVLYNFMCNS SCVGGMNRRP ILIIVTLETR DGQVLGRRCF EARICACPGR DRKADEDSIR
361 KQQVSDSTKN GDGTKRPFRQ NTHGIQMTSI KKRRSPDDEL LYLPVRGRET YEMLLKIKES
421 LELMQYLPQH TIETYRQQQQ QQHQHLLQKQ TSIQSPSSYG NSSPPLNKMN SMNKLPSVSQ
481 LINPQQRNAL TPTTIPDGMG ANIPMMGTHM PMAGDMNGLS PTQALPPPLS MPSTSHCTPP
541 PPYPTDCSIV SFLARLGCSS CLDYFTTQGL TTIYQIEHYS MDDLASLKIP EQFRHAIWKG
601 ILDHRQLHEF SSPSHLLRTP SSASTVSVGS SETRGERVID AVRFTLRQTI SFPPRDEWND
661 FNFDMDARRN KQQRIKEEGELocalizationUniProt · AlphaFold · HPA
Whether an antibody against TP63 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 130 nTPM
Expression across tissuesHPA
Tissue
- skin: 130 nTPM
- esophagus: 65 nTPM
- vagina: 53 nTPM
- skeletal muscle: 41 nTPM
- cervix: 37 nTPM
- thymus: 22 nTPM
Single-cell type
- myonuclei: 1,461 nCPM
- thymic myoid cells: 1,309 nCPM
- basal keratinocytes: 760 nCPM
- suprabasal keratinocytes: 528 nCPM
- respiratory basal cells: 415 nCPM
- basal prostatic cells: 387 nCPM
Immune cell
- memory B-cell: 0.7 nTPM
- basophil: 0.6 nTPM
- neutrophil: 0.4 nTPM
- naive B-cell: 0.3 nTPM
- eosinophil: 0.2 nTPM
- memory CD4 T-cell: 0.2 nTPM
Brain region
- cerebellum: 3.4 nTPM
- medulla oblongata: 3.1 nTPM
- midbrain: 2.9 nTPM
- hypothalamus: 2.7 nTPM
- hippocampal formation: 2.6 nTPM
- cerebral cortex: 2.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TP63.
Disease | AllUniProt
Conditions TP63 is implicated in, by any mechanism.
- Acro-dermato-ungual-lacrimal-tooth syndrome (ADULT syndrome) MIM:103285
- Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) MIM:106260
- Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3) MIM:604292
- Split-hand/foot malformation 4 (SHFM4) MIM:605289
- Limb-mammary syndrome (LMS) MIM:603543
- Rapp-Hodgkin syndrome (RHS) MIM:129400
- Orofacial cleft 8 (OFC8) MIM:618149
- Premature ovarian failure 21 (POF21) MIM:620311
Disease | GeneticClinVar
132 pathogenic / likely-pathogenic of 837 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- TP63-Related Spectrum Disorders
- Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3
- Rapp-Hodgkin syndrome
- Split hand-foot malformation 4
- TP63-related disorder
ReferencesPubMed · IEDB
Publications for TP63 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
7 publications
- High Prevalence and Disease Correlation of Autoantibodies Against p40 Encoded by Long Interspersed Nuclear Elements in Systemic Lupus Erythematosus.
2020 · Arthritis Rheumatol · RCR 1.3 · 37 citations - Oral lichen planus and the p53 family: what do we know?
2011 · J Oral Pathol Med · RCR 0.8 · 19 citations - Tp63 in oral development, neoplasia, and autoimmunity.
2012 · J Dent Res · RCR 0.7 · 22 citations - IgG and IgA autoantibodies against L1 ORF1p expressed in granulocytes correlate with granulocyte consumption and disease activity in pediatric systemic lupus erythematosus.
2021 · Arthritis Res Ther · RCR 0.6 · 12 citations - ELISA test for p63 antibodies in chronic ulcerative stomatitis.
2010 · Oral Dis · RCR 0.6 · 16 citations
Show 2 more
- The use of a novel ELISA method for detection of antibodies against p63 in sera from patients diagnosed with oral and/or genital and skin lichen planus.
2010 · J Oral Pathol Med · RCR 0.6 · 16 citations - Circulating antibodies to p40(AIS) in the sera of respiratory tract cancer patients.
2000 · Int J Cancer · RCR 0.3 · 14 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.21
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- cellular senescence
- chromatin remodeling
- cloacal septation
- cranial skeletal system development
- determination of adult lifespan
- DNA damage response
- embryonic forelimb morphogenesis
- embryonic hindlimb morphogenesis
- epithelial cell development
- establishment of planar polarity
- establishment of skin barrier
- female genitalia morphogenesis
- hair follicle morphogenesis
- intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
- keratinocyte differentiation
- keratinocyte proliferation
- negative regulation of cellular senescence
- negative regulation of DNA-templated transcription
- negative regulation of intracellular estrogen receptor signaling pathway
- negative regulation of keratinocyte differentiation
- negative regulation of mesoderm development
- negative regulation of transcription by RNA polymerase II
- neuron apoptotic process
- Notch signaling pathway
- odontogenesis of dentin-containing tooth
- polarized epithelial cell differentiation
- positive regulation of apoptotic signaling pathway
- positive regulation of cell cycle G1/S phase transition
- positive regulation of DNA-templated transcription
- positive regulation of fibroblast apoptotic process
- positive regulation of keratinocyte proliferation
- positive regulation of Notch signaling pathway
- positive regulation of osteoblast differentiation
- positive regulation of somatic stem cell population maintenance
- positive regulation of stem cell proliferation
- positive regulation of transcription by RNA polymerase II
- post-anal tail morphogenesis
- prostatic bud formation
- protein tetramerization
- proximal/distal pattern formation
- regulation of apoptotic process
- regulation of epidermal cell division
- skeletal system development
- skin morphogenesis
- spermatogenesis
- squamous basal epithelial stem cell differentiation involved in prostate gland acinus development
- stem cell proliferation
- sympathetic nervous system development
- transcription by RNA polymerase II
- ectoderm and mesoderm interaction
- epidermal cell division
Molecular functions
- chromatin binding
- damaged DNA binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- identical protein binding
- MDM2/MDM4 family protein binding
- metal ion binding
- p53 binding
- promoter-specific chromatin binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- WW domain binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Sterile alpha motif domain
- p53 tumour suppressor family
- p53-like transcription factor, DNA-binding domain superfamily
- p53, tetramerisation domain
- p53, DNA-binding domain
- p53/RUNT-type transcription factor, DNA-binding domain superfamily
- Sterile alpha motif/pointed domain superfamily
- p53-like tetramerisation domain superfamily
- p53, central conserved site
- P53 DNA-binding domain
- SAM domain (Sterile alpha motif)
- P53 tetramerisation motif
- Tumour protein p63, SAM domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TP63 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TP63 as an antibody target. Whether an autoantibody or antibody against TP63 could matter depends on whether native TP63 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TP63 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TP63 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...